[Congressional Record Volume 170, Number 119 (Tuesday, July 23, 2024)]
[Senate]
[Page S5255]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 2990. Mr. CORNYN submitted an amendment intended to be proposed by 
him to the bill S. 4638, to authorize appropriations for fiscal year 
2025 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

        At the end of subtitle E of title VII, add the following:

     SEC. 750. REGENERATIVE MEDICINE TECHNOLOGIES STRATEGY.

       (a) In General.--Not later than May 1, 2025, the Assistant 
     Secretary of Defense for Health Affairs, in coordination with 
     the Surgeons General of the Armed Forces and the Joint Staff 
     Surgeon, shall develop a strategy for regenerative medicine 
     technologies to support health of and return to duty by 
     members of the Armed Forces following traumatic injuries 
     sustained in training and combat operations.
       (b) Elements.--The strategy required under subsection (a) 
     shall, at a minimum--
       (1) focus on addressing medical challenges experienced by 
     members of the Armed Forces in training and combat operations 
     in which regenerative medicine technologies, including 
     anatomically-precise therapeutics, can be used to treat 
     vertebral, orthopedic, craniofacial, and musculoskeletal 
     injuries;
       (2) identify partnerships with academic medical centers, 
     industry, nonprofit organizations, and small businesses in 
     regenerative medicine to support existing and future medical 
     requirements of members of the Armed Forces;
       (3) identify laboratory and medical product development 
     requirements of the Department of Defense, including research 
     and development, to support transition and fielding of 
     regenerative medicine technologies;
       (4) identify gaps in regenerative medicine capabilities and 
     actions needed to close or mitigate those gaps; and
       (5) provide recommendations to transition regenerative 
     medicine technologies into clinical practice to treat 
     vertebral, orthopedic, craniofacial, and musculoskeletal 
     injuries sustained in training and combat operations.
       (c) Briefing.--Not later than 30 days after completion of 
     the strategy required under subsection (a), the Assistant 
     Secretary of Defense for Health Affairs shall provide to the 
     congressional defense committees a briefing on the strategy.
                                 ______